Dr Jake Rance
BA (Hons) Class 1, The University of Sydney, 1991
PhD, Utrecht University, The Netherlands, 2018
Jake joined the Centre for Social Research in Health (CSRH) following nearly a decade working in harm reduction services in Sydney鈥檚 Kings Cross.聽 This included outreach work with the Kirketon Road Centre (KRC) and a number of years as the Counselling Unit Manager of the Sydney Medically Supervised Injecting Centre (MSIC).聽Jake has a disciplinary background in social anthropology, philosophy, politics聽and cultural studies, graduating from The University of Sydney in 1991 with a BA (Hons) Class 1 in Social Anthropology and completing his PhD from Utrecht University, The Netherlands, in 2018.聽
Jake's research primarily concerns people who inject drugs, including those affected by hepatitis C and/or incarceration. Combining qualitative methods, empirical data, and social theory 鈥 particularly Foucauldian and new materialist approaches 鈥 his work endeavours to make sense of the complexities of lived experience. Jake's work is strongly informed by a sense of the ethical and political responsibilities that lie at the heart of knowledge production in the field of illicit and injecting drug use.
Jake sits on the editorial board of the International Journal of Drug Policy and the Harm Reduction Journal.聽He works closely with government and non-government organisations engaged in advocacy, health promotion, and service provision for people who use inject drugs. Jake聽is secretary and board member of Harm Reduction Australia,聽a national organisation committed聽to reducing the health, social and economic harms potentially associated with drug use. Jake is also a longstanding community member of NUAA, the state's drug-user organisation.
Jake is currently working on聽FOpIT, the Feasibility of Opioid聽injectable Treatment, Australia's first-ever trial of injectable opioid treatment.
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Treloar, T. Lancaster, K., Rhodes, T., Bryant, J., Brener, L., Rance, J., Lafferty, L. (2022-2023). Finding the 鈥榤issing鈥 in the hepatitis C response in NSW: A systemic response. NSW Health 鈥楤RISE鈥 (BBV, STIs and Viral Hepatitis Research Program 2020-2024) 国产精品 Grant number: RG191231-Q RE399. $44,904
Bryant, J., Rance, J., Treloar, C. & Brener, L. (2022-2023). A study of social media messages to promote hepatitis B testing and connection to care among the Vietnamese community in NSW. 国产精品 Grant number: RG221593. $69,920
Brener, L., Bryant, J., Rance, J., Broady, T., Mao, L. & Treloar, C. (2020-2022). Informing hepatitis B prevention, testing and treatment programs in Chinese and Vietnamese communities in Australia through the international student body. Australian Government Department of Health. 国产精品 Grant number: RG192416-A. $165,000
Brener, L., Bryant, J., Rance, J. & Treloar, C. (2020-2021). The impact of COVID-19 on harm reduction services. NSW Health 鈥楤RISE鈥 (BBV, STIs and Viral Hepatitis Research Program 2020-2024) 国产精品 Grant number: RG191231-J. $115,000
Brener, L., Rance, J., Bryant, J., Treloar, C., & Ritter, A. (2018-2019). Evaluation of NADA鈥檚 Consumer Participation Project. Network of Alcohol and other Drug Agencies (NADA) 国产精品 Grant number: RG180231. $62,714.
MacLean, S., Bryant, J., Best, D., Room, R., Wilson, A., Bruun, A., Rance, J. (2012-2014) Characteristics of vulnerable young people in inner-city areas who use alcohol and other drugs: policing and pathways to diversion and care. National Drug Law Enforcement Research Fund (NDLERF) 国产精品 Grant number: RG133659. $173, 942
Treloar, C., Rance, J. (2012-2014) Evaluation of NUAA鈥檚 Consumer Participation in Drug treatment Project. NSW Users & AIDS Association (NUAA) 国产精品 Grant number: RG114311. $104,102
国产精品 ADA ECAN (Early Career Academics Network) Award for Research Excellence 2021, for Rance, Lancaster & Rhodes (2021) article (see above)
ANZSOG/Australian Political Studies Association Policy Studies Prize 2020, for Lancaster, Rhodes & Rance (2020) article (see above)
New Investigator Scholarship, 7th International Symposium on Hepatitis Care in Substance Users (INHSU) Cascais, 2018
鈥楤est Social Science Abstract鈥, 7th International Symposium on Hepatitis Care in Substance Users (INHSU) Cascais, 2018
Jake is secretary of聽Harm Reduction Australia (HRA), a national membership-based organisation committed to reducing the health, social and economic harms potentially associated with drug use. He is also a member of the , the peak drug-user advocate organisation in NSW, Australia, and Unharm, a not-for-profit charity committed to campaigning for fair and pragmatic alternatives to existing drug policies.
Jake works closely with government and non-government organisations (NGO) engaged in advocacy, health promotion and service provision for people who use illicit drugs.
Jake currently聽sits on a number of advisory boards: the聽User鈥檚 News聽Editorial Advisory Committee (NUAA); South East Sydney Local Health District (SESLHD) Hepatitis C Health Promotion & Prevention Advisory Group; and the SESLHD Drug and Alcohol Consumer Participation Project Advisory Committee.聽